Close
Conference
series event

From global to local: addressing the threat of AMR to STI control

This two-day conference will bring together experts working at the interface of antimicrobial resistance (AMR) and STI research, policy and practice. Themes covered will include surveillance, treatment guidelines, new treatment initiatives, new diagnostic initiatives, antibiotic stewardship, and vaccines.

Blue-planet-earth-globe

Anti-microbial resistance (AMR) in sexually transmitted infections (STIs) is a major public health threat, with Neisseria gonorrhoeae being designated as a “high priority antibiotic resistant pathogen” by the World Health Organization (WHO). In the United Kingdom, the O’Neill review recommended that no antibiotics should be prescribed before an appropriate diagnostic test result is available in high-income countries. This is ambitious for the UK, let alone for most low- and middle-income countries where syndromic management is commonplace. In the absence of new diagnostics, antimicrobials and vaccines, combined with limited AMR surveillance data to inform national and global STI programming, there will be serious global sexual and reproductive health consequences.

This two-day conference will bring together experts working at the interface of antimicrobial resistance (AMR) and STI research, policy and practice. Themes covered will include surveillance, treatment guidelines, new treatment initiatives, new diagnostic initiatives, antibiotic stewardship, and vaccines.

The aims of the conference are to:

  • Develop a network to share knowledge and experiences of effective strategies and bottlenecks for tackling STI AMR, both locally and globally
  • Identify bottlenecks and solutions for tackling STI AMR
  • Develop a short- and long-term action plan on STIs and AMR

The conference is being organised by LSHTM’s STI Research Interest Group (STIRIG), co-hosted with and supported by LSHTM’s AMR Centre, Public Health England, Bristol Health Partners’ Sexual Health Improvement Programme Health Integration Team (SHIP), and the World Health Organization.


Who should attend?

Anyone interested in AMR and/or STIs, including but not limited to: researchers, healthcare professionals, policy makers, commissioners and service providers.

 

Click here to view full agenda

 

Registration required 

Admission

Admission
Free but registration is required

Contact

Contact